RI · State regulatory reference
Rhode Island.
Moderate
Rhode Island permits telemedicine practice and prescribing under the Telemedicine Coverage Act (R.I. Gen. Laws § 27-81) and Board of Medical Licensure and Discipline rules at 216-RICR-40-05-1, which hold online prescribing to the same standard as in-person care and bar prescriptions issued solely on an online questionnaire. Pharmacy compounding rules (216-RICR-40-15-1) adopt USP <795>, <797>, and <800> by reference and bar compounding that is 'essentially a copy of a commercially available product,' mirroring federal 503A rather than adding a distinctive state restriction. No RI-specific board enforcement against peptide or GLP-1 compounding was located.
Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
An initial visit and prescribing may occur via real-time synchronous audio-video; RI does not mandate a prior in-person exam for non-controlled drugs, but questionnaire-only evaluation is deemed unprofessional conduct, and controlled substances require an established relationship (216-RICR-40-05-1; R.I. Gen. Laws § 27-81).
Compounding
The Board of Pharmacy (216-RICR-40-15-1) incorporates USP <795>/<797>/<800> by reference and prohibits compounding copies of commercially available products, tracking federal 503A with no state-specific GLP-1/semaglutide ban identified.
Sources